GlassScriptPhysician profile
Nora C Vera
NPI 1437682556
$2,200.53
in general payments reported to CMS, 2019-2025
21 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $17.99 · 2022: $189 · 2023: $530 · 2024: $425 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $853.89 | 2019-2025 | Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $274.18 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $201.66 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.06 | 2019-2023 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $123.52 | 2019 | |
| Dermavant Sciences, INC. | $117.90 | 2022-2024 | Vtama |
| Genzyme Corporation | $64.07 | 2023-2024 | |
| Amgen INC. | $55.79 | 2022-2023 | Otezla |
| Leo Pharma INC. | $45.40 | 2024-2025 | Adbry, Anzupgo |
| Helsinn Therapeutics (U.S.), INC. | $36.07 | 2023 | Valchlor |
| Lilly USA, LLC | $32.30 | 2022 | |
| Organon LLC | $29.38 | 2025 | Vtama |
| Convatec INC. | $28.25 | 2023 | |
| Smith+Nephew, INC. | $27.38 | 2022 | |
| Biofrontera INC. | $20.88 | 2024 | Ameluz, Rhodoled Xl, Xepi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.72 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pfizer INC. | $18.54 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.99 | 2020 | |
| Galderma Laboratories, L.P. | $16.94 | 2024 | |
| Hoffmann-La Roche Limited | $13.79 | 2019 | |
| Advanced Oxygen Therapy INC. | $5.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.